{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:21:32Z","timestamp":1792606892734,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.pcl.2022.01.009","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T20:28:18Z","timestamp":1654288098000},"page":"441-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hemostasis in Pediatric Extracorporeal Life Support"],"prefix":"10.1016","volume":"69","author":[{"given":"Amarilis A.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukhmi","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Chitlur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pcl.2022.01.009_bib4","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jtcvs.2006.11.050","article-title":"Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device","volume":"133","author":"Slaughter","year":"2007","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.pcl.2022.01.009_bib9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MAT.0b013e318038fc1f","article-title":"Early in\u00a0vivo experience with the pediatric Jarvik 2000 heart","volume":"53","author":"Kilic","year":"2007","journal-title":"ASAIO J"},{"key":"10.1016\/j.pcl.2022.01.009_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/j.pcsu.2016.09.003","article-title":"Closing in on the PumpKIN Trial of the Jarvik 2015 Ventricular Assist Device","volume":"20","author":"Baldwin","year":"2017","journal-title":"Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu"},{"key":"10.1016\/j.pcl.2022.01.009_bib12","series-title":"American college of cardiology","article-title":"Mechanical circulatory support in congenital heart disease","author":"Mascio","year":"2018"},{"issue":"6","key":"10.1016\/j.pcl.2022.01.009_bib13","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1164\/rccm.201609-1945OC","article-title":"Factors associated with bleeding and thrombosis in children receiving extracorporeal membrane oxygenation","volume":"196","author":"Dalton","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pcl.2022.01.009_bib14","series-title":"ECLS registry report, International Summary","first-page":"1","year":"2017"},{"issue":"6","key":"10.1016\/j.pcl.2022.01.009_bib15","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.athoracsur.2020.09.003","article-title":"Fourth annual pediatric interagency registry for mechanical circulatory support (pedimacs) report","volume":"110","author":"Morales","year":"2020","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.pcl.2022.01.009_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MAT.0000000000000798","article-title":"Small left ventricular size is an independent risk factor for ventricular assist device thrombosis","volume":"65","author":"Chivukula","year":"2019","journal-title":"ASAIO J"},{"issue":"2","key":"10.1016\/j.pcl.2022.01.009_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/PCC.0000000000002102","article-title":"Platelet transfusion practice and related outcomes in pediatric extracorporeal membrane oxygenation","volume":"21","author":"Cashen","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.pcl.2022.01.009_bib18","doi-asserted-by":"crossref","first-page":"612467","DOI":"10.3389\/fped.2020.612467","article-title":"Challenges in maintaining the hemostatic balance in children undergoing extracorporeal membrane oxygenation: a systematic literature review","volume":"8","author":"Drop","year":"2020","journal-title":"Front Pediatr"},{"issue":"4","key":"10.1016\/j.pcl.2022.01.009_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5551\/jat.RV17031","article-title":"Acquired von willebrand syndrome associated with cardiovascular diseases","volume":"26","author":"Horiuchi","year":"2019","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.pcl.2022.01.009_bib20","article-title":"Complications in children with ventricular assist devices: systematic review and meta-analyses","author":"George","year":"2021","journal-title":"Heart Fail Rev"},{"issue":"7","key":"10.1016\/j.pcl.2022.01.009_bib21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/MAT.0000000000000878","article-title":"Marked Practice variation in antithrombotic care with the berlin heart EXCOR pediatric ventricular assist device","volume":"65","author":"May","year":"2019","journal-title":"ASAIO J"},{"key":"10.1016\/j.pcl.2022.01.009_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.thromres.2018.02.145","article-title":"Antithrombotic therapies in children on durable ventricular assist devices: a literature review","volume":"172","author":"Huang","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.pcl.2022.01.009_bib23","series-title":"Pediatric critical care: text and study guide","first-page":"55","article-title":"Endothelial interactions and coagulation","author":"Trung","year":"2021"},{"issue":"1","key":"10.1016\/j.pcl.2022.01.009_bib24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s13054-016-1570-4","article-title":"The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology","volume":"20","author":"Millar","year":"2016","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.pcl.2022.01.009_bib25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1525-1594.2007.00391.x","article-title":"The effect of surface roughness on activation of the coagulation system and platelet adhesion in rotary blood pumps","volume":"31","author":"Linneweber","year":"2007","journal-title":"Artif Organs"},{"key":"10.1016\/j.pcl.2022.01.009_bib26","doi-asserted-by":"crossref","first-page":"625632","DOI":"10.3389\/fped.2021.625632","article-title":"Hemostatic challenges in pediatric critical care medicine-hemostatic balance in VAD","volume":"9","author":"Ghbeis","year":"2021","journal-title":"Front Pediatr"},{"issue":"7","key":"10.1016\/j.pcl.2022.01.009_bib27","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1097\/00003246-200007000-00067","article-title":"The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates","volume":"28","author":"Cheung","year":"2000","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.pcl.2022.01.009_bib28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ejcts\/ezu510","article-title":"Platelet dysfunction and acquired von Willebrand syndrome in patients with left ventricular assist devices","volume":"48","author":"Baghai","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"issue":"7","key":"10.1016\/j.pcl.2022.01.009_bib29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/aor.13646","article-title":"Impact of high mechanical shear stress and oxygenator membrane surface on blood damage relevant to thrombosis and bleeding in a pediatric ECMO circuit","volume":"44","author":"Sun","year":"2020","journal-title":"Artif Organs"},{"issue":"5","key":"10.1016\/j.pcl.2022.01.009_bib30","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/2150135116651836","article-title":"Pediatric acquired von willebrand disease with berlin heart excor ventricular assist device support","volume":"7","author":"Gossai","year":"2016","journal-title":"World J Pediatr Congenit Heart Surg"},{"issue":"2","key":"10.1016\/j.pcl.2022.01.009_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MAT.0b013e318283815c","article-title":"Mechanistic pathway(s) of acquired von willebrand syndrome with a continuous-flow ventricular assist device: in\u00a0vitro findings","volume":"59","author":"Dassanayaka","year":"2013","journal-title":"ASAIO J"},{"issue":"10","key":"10.1016\/j.pcl.2022.01.009_bib32","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/PCC.0000000000002009","article-title":"Acquired von willebrand syndrome in pediatric extracorporeal membrane oxygenation patients: a single institution's experience","volume":"20","author":"Ruth","year":"2019","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"10.1016\/j.pcl.2022.01.009_bib33","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/ejcts\/ezy408","article-title":"Acquired von Willebrand syndrome in paediatric patients during mechanical circulatory support","volume":"55","author":"Kubicki","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"10.1016\/j.pcl.2022.01.009_bib34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.PCC.0000231946.88688.07","article-title":"Heparin-induced thrombocytopenia in a pediatric patient receiving extracorporeal membrane oxygenation managed with argatroban","volume":"7","author":"Scott","year":"2006","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"10.1016\/j.pcl.2022.01.009_bib35","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/01.mat.0000185630.83985.49","article-title":"Heparin-induced thrombocytopenia complicating support by the Berlin Heart","volume":"51","author":"Eghtesady","year":"2005","journal-title":"ASAIO J"},{"key":"10.1016\/j.pcl.2022.01.009_bib36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fmed.2018.00321","article-title":"Novel surfaces in extracorporeal membrane oxygenation circuits","volume":"5","author":"Ontaneda","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"10.1016\/j.pcl.2022.01.009_bib37","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1021\/acsbiomaterials.1c00758","article-title":"Anti-thrombogenic surface coatings for extracorporeal membrane oxygenation: a narrative review","volume":"7","author":"Zhang","year":"2021","journal-title":"ACS Biomater Sci Eng"},{"issue":"4","key":"10.1016\/j.pcl.2022.01.009_bib38","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jtcvs.2017.03.149","article-title":"New anticoagulant coatings and hemostasis assessment tools to avoid complications with pediatric left ventricular assist devices","volume":"154","author":"Leslie","year":"2017","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.pcl.2022.01.009_bib39","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0006-291X(76)90558-1","article-title":"The separation of active and inactive forms of heparin","volume":"69","author":"Lam","year":"1976","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.pcl.2022.01.009_bib40","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0049-3848(76)90105-5","article-title":"Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration","volume":"9","author":"Andersson","year":"1976","journal-title":"Thromb Res"},{"issue":"22","key":"10.1016\/j.pcl.2022.01.009_bib41","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199105303242206","article-title":"Heparin","volume":"324","author":"Hirsh","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.pcl.2022.01.009_bib42","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.thromres.2008.07.009","article-title":"In\u00a0vivo age dependency of unfractionated heparin in infants and children","volume":"123","author":"Newall","year":"2009","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.pcl.2022.01.009_bib43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00043426-199021000-00019","article-title":"Development of the hemostatic system in the neonate and young infant","volume":"12","author":"Andrew","year":"1990","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.pcl.2022.01.009_bib44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V70.1.165.165","article-title":"Development of the human coagulation system in the full-term infant","volume":"70","author":"Andrew","year":"1987","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.pcl.2022.01.009_bib45","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1203\/00006450-198107000-00007","article-title":"Heparin clearance in the newborn","volume":"15","author":"McDonald","year":"1981","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.pcl.2022.01.009_bib46","first-page":"12","article-title":"Heparin-induced thrombocytopenia in the pediatric population: a review of current literature","volume":"17","author":"Vakil","year":"2012","journal-title":"J\u00a0Pediatr Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.pcl.2022.01.009_bib47","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/MAT.0000000000000122","article-title":"Bivalirudin for treatment of LVAD thrombosis: a case series","volume":"60","author":"Sylvia","year":"2014","journal-title":"ASAIO J"},{"issue":"3","key":"10.1016\/j.pcl.2022.01.009_bib48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/cc11314","article-title":"Bivalirudin and post-cardiotomy ECMO: a word of caution","volume":"16","author":"Ranucci","year":"2012","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.pcl.2022.01.009_bib49","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1051\/ject\/201446094","article-title":"Bivalirudin in venovenous extracorporeal membrane oxygenation","volume":"46","author":"Jyoti","year":"2014","journal-title":"J\u00a0Extra Corpor Technol"},{"issue":"4","key":"10.1016\/j.pcl.2022.01.009_bib50","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1097\/PCC.0b013e31827200b6","article-title":"Bivalirudin in pediatric patients maintained on extracorporeal life support","volume":"14","author":"Nagle","year":"2013","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"10.1016\/j.pcl.2022.01.009_bib51","doi-asserted-by":"crossref","first-page":"R275","DOI":"10.1186\/cc10556","article-title":"Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation","volume":"15","author":"Ranucci","year":"2011","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.pcl.2022.01.009_bib52","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.jvca.2012.07.019","article-title":"Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study","volume":"27","author":"Pieri","year":"2013","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"3","key":"10.1016\/j.pcl.2022.01.009_bib53","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1055\/s-0038-1653787","article-title":"A\u00a0comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers","volume":"73","author":"Eriksson","year":"1995","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.pcl.2022.01.009_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2000-9497","article-title":"Comparative pharmacokinetics of LMWHs","volume":"26","author":"Samama","year":"2000","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl 1","key":"10.1016\/j.pcl.2022.01.009_bib55","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/00001721-199506001-00010","article-title":"The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin","volume":"6","author":"Hoppensteadt","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"8","key":"10.1016\/j.pcl.2022.01.009_bib56","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/MAT.0000000000001093","article-title":"Utilization and outcomes of children treated with direct thrombin inhibitors on paracorporeal ventricular assist device support","volume":"66","author":"VanderPluym","year":"2020","journal-title":"ASAIO J"},{"issue":"4","key":"10.1016\/j.pcl.2022.01.009_bib57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPH.0b013e3180463626","article-title":"Argatroban for anticoagulation in pediatric patients with heparin-induced thrombocytopenia requiring extracorporeal life support","volume":"29","author":"Potter","year":"2007","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.pcl.2022.01.009_bib58","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3468(97)90701-6","article-title":"Application of a new anticoagulant (Nafamostat Mesilate) to control hemorrhagic complications during extracorporeal membrane oxygenation--a preliminary report","volume":"32","author":"Nagaya","year":"1997","journal-title":"J\u00a0Pediatr Surg"},{"issue":"6","key":"10.1016\/j.pcl.2022.01.009_bib59","first-page":"1366","article-title":"Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes","volume":"26","author":"Blanco","year":"1999","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.pcl.2022.01.009_bib60","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/MAT.0b013e318213f9e0","article-title":"Addition of acetylsalicylic acid to heparin for anticoagulation management during pumpless extracorporeal lung assist","volume":"57","author":"Bein","year":"2011","journal-title":"ASAIO J"},{"issue":"2","key":"10.1016\/j.pcl.2022.01.009_bib61","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nrd2957","article-title":"Antiplatelet therapies for the treatment of cardiovascular disease","volume":"9","author":"Michelson","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.pcl.2022.01.009_bib62","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.healun.2013.01.1056","article-title":"Antithrombotic strategies in children receiving long-term Berlin Heart EXCOR ventricular assist device therapy","volume":"32","author":"Rutledge","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.pcl.2022.01.009_bib63","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/MAT.0000000000000434","article-title":"Berlin Heart EXCOR Pediatric VAD IDE study investigators. Antithrombotic therapy in a prospective trial of a pediatric ventricular assist device","volume":"62","author":"Steiner","year":"2016","journal-title":"ASAIO J"},{"issue":"11","key":"10.1016\/j.pcl.2022.01.009_bib64","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.healun.2017.05.020","article-title":"Impact of a modified anti-thrombotic guideline on stroke in children supported with a pediatric ventricular assist device","volume":"36","author":"Rosenthal","year":"2017","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"12","key":"10.1016\/j.pcl.2022.01.009_bib65","doi-asserted-by":"crossref","first-page":"e006663","DOI":"10.1161\/CIRCOUTCOMES.120.006663","article-title":"Investigators\u2217 A. ABCs of stroke prevention: improving stroke outcomes in children supported with a ventricular assist device in a quality improvement network","volume":"13","author":"Villa","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6","key":"10.1016\/j.pcl.2022.01.009_bib66","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MAT.0000000000001373","article-title":"HVAD usage and outcomes in the current pediatric ventricular assist device field: an advanced cardiac therapies improving outcomes network (ACTION) analysis","volume":"67","author":"Auerbach","year":"2021","journal-title":"ASAIO J"},{"issue":"1","key":"10.1016\/j.pcl.2022.01.009_bib67","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/PCC.0000000000000278","article-title":"The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and increased circuit life","volume":"16","author":"Northrop","year":"2015","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"10.1016\/j.pcl.2022.01.009_bib68","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/cc4822","article-title":"Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis","volume":"10","author":"Wiedermann","year":"2006","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.pcl.2022.01.009_bib69","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1160\/TH05-01-0047","article-title":"Developmental haemostasis. Impact for clinical haemostasis laboratories","volume":"95","author":"Monagle","year":"2006","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.pcl.2022.01.009_bib70","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jpedsurg.2016.10.047","article-title":"Outcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation","volume":"52","author":"Stansfield","year":"2017","journal-title":"J\u00a0Pediatr Surg"},{"issue":"8","key":"10.1016\/j.pcl.2022.01.009_bib71","first-page":"717","article-title":"Evaluation of heparin anti-factor Xa levels following antithrombin supplementation in pediatric patients supported with extracorporeal membrane oxygenation","volume":"25","author":"Gordon","year":"2020","journal-title":"J\u00a0Pediatr Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.pcl.2022.01.009_bib72","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/PCC.0000000000000955","article-title":"Antithrombin concentrate use in pediatric extracorporeal membrane oxygenation: a multicenter cohort study","volume":"17","author":"Wong","year":"2016","journal-title":"Pediatr Crit Care Med"},{"issue":"5","key":"10.1016\/j.pcl.2022.01.009_bib73","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2350\/09-09-0704-OA.1","article-title":"Laboratory and clinical predictors of thrombosis and hemorrhage in 29 pediatric extracorporeal membrane oxygenation nonsurvivors","volume":"13","author":"Reed","year":"2010","journal-title":"Pediatr Dev Pathol"},{"issue":"3","key":"10.1016\/j.pcl.2022.01.009_bib74","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/MAT.0000000000000986","article-title":"Correlation among antifactor Xa, activated partial thromboplastin time, and heparin dose and association with pediatric extracorporeal membrane oxygenation complications","volume":"66","author":"McMichael","year":"2020","journal-title":"ASAIO J"},{"issue":"6","key":"10.1016\/j.pcl.2022.01.009_bib75","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/MAT.0000000000000571","article-title":"Coagulation profile is not a predictor of acute cerebrovascular events in pediatric extracorporeal membrane oxygenation patients","volume":"63","author":"Anton-Martin","year":"2017","journal-title":"ASAIO J"},{"issue":"1","key":"10.1016\/j.pcl.2022.01.009_bib76","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/MAT.0b013e318279854a","article-title":"Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation","volume":"59","author":"Bembea","year":"2013","journal-title":"ASAIO J"},{"key":"10.1016\/j.pcl.2022.01.009_bib77","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fped.2016.00067","article-title":"Anticoagulation management and monitoring during pediatric extracorporeal life support: a review of current issues","volume":"4","author":"Ryerson","year":"2016","journal-title":"Front Pediatr"},{"issue":"2","key":"10.1016\/j.pcl.2022.01.009_bib78","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1097\/PCC.0000000000000028","article-title":"Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation\u2217","volume":"15","author":"Liveris","year":"2014","journal-title":"Pediatr Crit Care Med"},{"issue":"8","key":"10.1016\/j.pcl.2022.01.009_bib79","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0267659117720494","article-title":"Coagulation monitoring correlation with heparin dose in pediatric extracorporeal life support","volume":"32","author":"Moynihan","year":"2017","journal-title":"Perfusion"},{"key":"10.1016\/j.pcl.2022.01.009_bib80","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.thromres.2017.07.006","article-title":"Should we abandon the APTT for monitoring unfractionated heparin?","volume":"157","author":"Arachchillage","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.pcl.2022.01.009_bib81","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1182\/asheducation.V2012.1.460.3798662","article-title":"Coagulation assays and anticoagulant monitoring","volume":"2012","author":"Funk","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"7","key":"10.1016\/j.pcl.2022.01.009_bib82","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1056\/NEJM197208172870703","article-title":"A\u00a0prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time","volume":"287","author":"Basu","year":"1972","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.pcl.2022.01.009_bib83","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1055\/s-0039-1697950","article-title":"Anti-factor Xa-based anticoagulation during extracorporeal membrane oxygenation: potential problems and possible solutions","volume":"46","author":"Ranucci","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"10.1016\/j.pcl.2022.01.009_bib84","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s11239-016-1468-7","article-title":"Prospective evaluation of a bivalirudin to warfarin transition nomogram","volume":"43","author":"Hohlfelder","year":"2017","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"4","key":"10.1016\/j.pcl.2022.01.009_bib85","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1309\/AJCPQOD9WFPEYY0H","article-title":"Measuring direct thrombin inhibitors with routine and dedicated coagulation assays: which assay is helpful?","volume":"138","author":"Curvers","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pcl.2022.01.009_bib86","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2019.12.007","article-title":"Monitoring bivalirudin therapy in children on extracorporeal circulatory support devices: thromboelastometry versus routine coagulation testing","volume":"186","author":"Teruya","year":"2020","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.pcl.2022.01.009_bib87","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bpa.2012.04.003","article-title":"Coagulation management in patients undergoing mechanical circulatory support","volume":"26","author":"G\u00f6rlinger","year":"2012","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"3","key":"10.1016\/j.pcl.2022.01.009_bib88","doi-asserted-by":"crossref","first-page":"329","DOI":"10.21037\/acs-2020-cfmcs-18","article-title":"Pediatric ventricular assist device registries: update and perspectives in the era of miniaturized continuous-flow pumps","volume":"10","author":"Lichtenstein","year":"2021","journal-title":"Ann Cardiothorac Surg"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395522000098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395522000098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:26:24Z","timestamp":1758475584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395522000098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0031395522000098"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2022.01.009","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemostasis in Pediatric Extracorporeal Life Support","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2022.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}